This study investigated whether the use of tranexamic acid (TXA)
decreased blood loss and transfusion related cost following surface
replacement arthroplasty (SRA). A retrospective review of patients treated with TXA during a
SRA, who did not receive autologous blood (TXA group) was performed.
Two comparison groups were established; the first group comprised
of patients who donated their own blood pre-operatively (auto group)
and the second of patients who did not donate blood pre-operatively
(control). Outcomes included transfusions, post-operative haemoglobin
(Hgb), complications, and length of post-operative stay. Aims
Methods
Haematomas, drainage, and other non-infectious
wound complications following total knee replacement (TKR) have
been associated with long-term sequelae, in particular, deep infection.
However, the impact of these wound complications on clinical outcome
is unknown. This study compares results in 15 patients re-admitted
for wound complications within 90 days of TKR to 30 matched patients
who underwent uncomplicated total knee replacements. Patients with
wound complications had a mean age of 66 years (49 to 83) and mean
body mass index (BMI) of 37 (21 to 54), both similar to that of
patients without complications (mean age 65 years and mean BMI 35). Those
with complications had lower mean Knee Society function scores (46
(0 to 100 Cite this article:
